chr16-29816710-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024516.4(PAGR1):c.185C>T(p.Ser62Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024516.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAGR1 | NM_024516.4 | c.185C>T | p.Ser62Phe | missense_variant | 1/3 | ENST00000320330.8 | NP_078792.1 | |
MVP-DT | NR_186424.1 | n.246+2830G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAGR1 | ENST00000320330.8 | c.185C>T | p.Ser62Phe | missense_variant | 1/3 | 1 | NM_024516.4 | ENSP00000326519.6 | ||
ENSG00000280893 | ENST00000609618.2 | n.*126C>T | non_coding_transcript_exon_variant | 4/6 | 5 | ENSP00000476774.2 | ||||
ENSG00000280893 | ENST00000609618.2 | n.*126C>T | 3_prime_UTR_variant | 4/6 | 5 | ENSP00000476774.2 | ||||
MVP-DT | ENST00000569039.5 | n.245+2830G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2023 | The c.185C>T (p.S62F) alteration is located in exon 1 (coding exon 1) of the PAGR1 gene. This alteration results from a C to T substitution at nucleotide position 185, causing the serine (S) at amino acid position 62 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.